National Drug Authority Urged to Intensify Crackdown on Counterfeit Medicines

The presence of substandard and falsified medical products in the market remains a critical concern for public health across Uganda. Recent regulatory actions, including product recalls by the National Drug Authority (NDA), underline the persistent vulnerability of the healthcare supply chain to counterfeit goods.

While the authority’s interventions are essential for removing dangerous items from circulation, recurring incidents suggest that reactive measures alone are not enough. Ensuring that citizens have access to safe, genuine pharmaceuticals requires robust pre-market approvals, rigorous border surveillance, and swift punitive actions against illicit operators.

Public confidence in the healthcare system depends heavily on the predictability and effectiveness of regulatory oversight. As counterfeiters become increasingly sophisticated, the NDA must adopt advanced detection technologies and foster closer collaboration with local law enforcement agencies to dismantle illegal manufacturing and distribution networks.

Ultimately, protecting vulnerable populations from the devastating effects of fake drugs demands continuous vigilance and proactive enforcement strategies from all relevant stakeholders.

For more details, read the original report on Daily Monitor.